These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2901889)

  • 1. Calcium therapy for neuroleptic-induced extrapyramidal symptoms.
    Fernando ML; Manchanda R
    Br J Psychiatry; 1988 May; 152():722-3. PubMed ID: 2901889
    [No Abstract]   [Full Text] [Related]  

  • 2. Calcium and extrapyramidal side effects.
    El-Defrawi MH
    Am J Psychiatry; 1982 Aug; 139(8):1079. PubMed ID: 6124137
    [No Abstract]   [Full Text] [Related]  

  • 3. Another view of calcium and extrapyramidal side effects.
    Bailie GR; Nelson MV; Lesar T
    Am J Psychiatry; 1983 Nov; 140(11):1537-8. PubMed ID: 6137965
    [No Abstract]   [Full Text] [Related]  

  • 4. [Correction of an extrapyramidal neuroleptic syndrome with tryptophan and the dynamics of its concentration in the blood of patients].
    Balakleevskiĭ AI; Mitiukova TA; Vazhenin MM; Gaĭduk FM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(2):95-7. PubMed ID: 6112836
    [No Abstract]   [Full Text] [Related]  

  • 5. Role of amantadine in the management of neuroleptic-induced extrapyramidal syndromes: overview and pharmacology.
    Allen RM
    Clin Neuropharmacol; 1983; 6 Suppl 1():S64-73. PubMed ID: 6196112
    [No Abstract]   [Full Text] [Related]  

  • 6. Anticholinergics to treat antipsychotic-induced extrapyramidal symptoms: Time to avoid this practice.
    Koola MM
    Asian J Psychiatr; 2018 Jan; 31():100-101. PubMed ID: 29454175
    [No Abstract]   [Full Text] [Related]  

  • 7. Neuroleptic-induced extrapyramidal symptoms and serum calcium levels. Results of a pilot study.
    Kuny S; Binswanger U
    Neuropsychobiology; 1989; 21(2):67-70. PubMed ID: 2575718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recognition and management of acute neuroleptic-induced extrapyramidal motor and mental syndromes.
    Dose M
    Pharmacopsychiatry; 2000 Sep; 33 Suppl 1():3-13. PubMed ID: 11072761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical management of acute neuroleptic-induced extrapyramidal syndromes.
    Keepers GA; Casey DE
    Curr Psychiatr Ther; 1986; 23():139-57. PubMed ID: 2870879
    [No Abstract]   [Full Text] [Related]  

  • 10. The clinical use of anticholinergic drugs as treatment for extrapyramidal side effects of neuroleptic drugs.
    McEvoy JP
    J Clin Psychopharmacol; 1983 Oct; 3(5):288-302. PubMed ID: 6138370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ionized calcium and neuroleptic-induced extrapyramidal symptoms.
    Kuny S; Binswanger U
    Pharmacopsychiatry; 1988 Nov; 21(6):300-1. PubMed ID: 2907631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Buspirone suppression of neuroleptic-induced akathisia: multiple case reports.
    D'Mello DA; McNeil JA; Harris W
    J Clin Psychopharmacol; 1989 Apr; 9(2):151-2. PubMed ID: 2566629
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of piracetam on extrapyramidal side effects induced by neuroleptic drugs.
    Kabes J; Sikora J; Pisvejc J; Hanzlicek L; Skondia V
    Int Pharmacopsychiatry; 1982; 17(3):185-92. PubMed ID: 6128331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of the neuroleptic malignant syndrome with bromocriptine.
    Dhib-Jalbut S; Hesselbrock R; Brott T; Silbergeld D
    JAMA; 1983 Jul 22-29; 250(4):484-5. PubMed ID: 6134848
    [No Abstract]   [Full Text] [Related]  

  • 15. The potential of GABA-mimetics in the therapy of extrapyramidal disorders.
    Bartholini G; Lloyd KG
    J Neural Transm Suppl; 1980; (16):229-38. PubMed ID: 6107332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Amantadine in malignant neuroleptic syndrome].
    Rojtman M; Apter E; Lahav S; Tiano S
    Harefuah; 1981 Apr; 100(7):333. PubMed ID: 6115795
    [No Abstract]   [Full Text] [Related]  

  • 17. [Management of neuroleptic side-effects with piracetam (author's transl)].
    Sikora J; Kabes J; Pisvejc J
    Cesk Psychiatr; 1981 Apr; 77(2):137-42. PubMed ID: 6114800
    [No Abstract]   [Full Text] [Related]  

  • 18. Quantitative assessment of neuroleptic-induced extrapyramidal symptoms: clinical and nonclinical approaches.
    May PR; Lee MA; Bacon RC
    Clin Neuropharmacol; 1983; 6 Suppl 1():S35-51. PubMed ID: 6139165
    [No Abstract]   [Full Text] [Related]  

  • 19. Neuroleptics, extrapyramidal symptoms, and serum-calcium levels.
    el-Defrawi MH; Craig TJ
    Compr Psychiatry; 1984; 25(6):539-45. PubMed ID: 6150808
    [No Abstract]   [Full Text] [Related]  

  • 20. Neuroleptic malignant syndrome. Successful treatment with bromocriptine.
    Mueller PS; Vester JW; Fermaglich J
    JAMA; 1983 Jan; 249(3):386-8. PubMed ID: 6129331
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.